About Technology Issues FAQ

Links

Biomarker Development for the Clinical Activity of the mTOR Inhibitor Everolimus (RAD001): Processes, Limitations, and Further Proposals

Biomarker Development for the Clinical Activity of the mTOR Inhibitor Everolimus (RAD001): Processes, Limitations, and Further Proposals — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.